Evidence map›Paper›PMID 30544943›Full record

ArticleMolecules (Basel, Switzerland)2018

Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid.

Guru KrishnaKumar Viswanathan, Satabdee Mohapatra, Ashim Paul, Elad Arad, Raz Jelinek, Ehud Gazit, Daniel Segal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Guru KrishnaKumar ViswanathanSchool of Molecular Microbiology & Biotechnology, Tel Aviv University, Tel Aviv 69978, Israel. guru.vgkk@gmail.com.
Satabdee MohapatraSchool of Molecular Microbiology & Biotechnology, Tel Aviv University, Tel Aviv 69978, Israel. satabdeemohapatra@gmail.com.
Ashim PaulSchool of Molecular Microbiology & Biotechnology, Tel Aviv University, Tel Aviv 69978, Israel. ashim.ismu@gmail.com.
Elad AradDepartment of Chemistry, Ilse Katz Institute (IKI) for Nanoscale Science and Technology, Ben Gurion University of the Negev, Beer Sheva 84105, Israel. eladarad.ea@gmail.com.
Raz JelinekDepartment of Chemistry, Ilse Katz Institute (IKI) for Nanoscale Science and Technology, Ben Gurion University of the Negev, Beer Sheva 84105, Israel. razj@bgu.ac.il.
Ehud GazitSchool of Molecular Microbiology & Biotechnology, Tel Aviv University, Tel Aviv 69978, Israel. ehudg@post.tau.ac.il.
Daniel SegalSchool of Molecular Microbiology & Biotechnology, Tel Aviv University, Tel Aviv 69978, Israel. dsegal@post.tau.ac.il.
Tel Aviv University · ILBen-Gurion University of the Negev · IL

Funding

Israel Science Foundation 1130/13
6 · The paper itself

Abstract

PAP

Indexed as

Acid PhosphataseAmyloidBinding SitesColoring AgentsCongo RedDose-Response Relationship, DrugMolecular Docking SimulationNaphthoquinonesPeptide FragmentsProtein ConformationThermodynamicsTryptophanAcid PhosphataseAmyloidColoring AgentsCongo RedNaphthoquinonesPeptide Fragmentsprostatic acid phosphataseTryptophanamyloid inhibitionNQTrpPAP248–286 peptidepolypeptide aggregationsemen amyloids

Identifiers

PMID30544943
PMCPMC6320874
OpenAlexW2903666189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.